Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prometheus Biosciences, Inc. - Common Stock (NQ:RXDX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 15, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Prometheus Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Bellus Health Soars 98% As GSK Joins Buyout Bonanza With $2 Billion Deal ↗
Shares of its takeover candidate nearly doubled on the news. 
Via Investor's Business Daily
North America Could Possibly Emerge as the Market Leader for Billion Dollar Detox Drinks Industry
EQNX::TICKER_START (NASDAQ:CELH),(NASDAQ:OMER),(NYSE:MRK),(NASDAQ:RXDX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Expert Ratings for Prometheus Biosciences ↗
 
Via Benzinga
News headline image
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results ↗
U.S. stocks traded slightly lower toward the end of trading. The Dow traded down 0.07% to 33,862.05 while the NASDAQ fell 0.24% to 12,093.82. The S&P 500, also fell, dropping, 0.17% to 4,130.78. 
Via Benzinga
News headline image
These 3 Nasdaq Stocks Are on Fire Today: Here's Why ↗
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
News headline image
Why Shares of Prometheus Biosciences Are Soaring Monday ↗
Merck's $10.8 billion buyout offer sent the clinical-stage biotech stock higher. 
Via The Motley Fool
News headline image
Gold Drops Below $2,000; Charles Schwab Earnings Top Views ↗
U.S. stocks traded mostly flat midway through trading, following the release of economic data. The Dow traded up 0.01% to 33,890.03 while the NASDAQ fell 0.18% to 12,101.34. The S&P 500, also fell,... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗
 
Via Benzinga
News headline image
US Stocks Mostly Flat; NY Empire State Manufacturing Index Surges In April ↗
U.S. stocks traded mostly flat this morning, following the release of economic data. Following the market opening Monday, the Dow traded up 0.04% to 33,901.46 while the NASDAQ fell 0.09% to 12,112.19.... 
Via Benzinga
News headline image
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom ↗
Merck is branching into immune-mediated diseases with this takeover. 
Via Investor's Business Daily
News headline image
PRST Stock Alert: What to Know About Red-Hot Presto Automation Today ↗
Presto Automation (PRST) stock is seeing massive gains with heavy trading on Monday despite a lack of news from the AI company. 
Via InvestorPlace
News headline image
Why Is NIO Stock Up Today? ↗
Nio (NIO) stock is climbing higher on Monday after the EV company announced the launch of its new power charging stations. 
Via InvestorPlace
News headline image
RXDX Stock Alert: The $10.8 Billion Reason Prometheus Biosciences Is Surging Today ↗
RXDX stock is soaring today as Merck is officially acquiring Prometheus Biosciences. Here's what investors should know today. 
Via InvestorPlace
News headline image
Why Is SAI.TECH Global (SAI) Stock Down 32% Today? ↗
SAI.TECH Global (SAI) stock is down on Monday despite a lack of news concerning the Bitcoin (BTC-USD) mining and clean energy company. 
Via InvestorPlace
News headline image
Why Is Marpai (MRAI) Stock Down 40% Today? ↗
Marpai (MRAI) stock is taking a beating on Monday after the company announced a proposed public offering for its shares. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
XPeng Is Charging Higher, but This Biotech Stock Is Monday's Biggest Winner ↗
Markets are watching corporate earnings very carefully. 
Via The Motley Fool
News headline image
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today? ↗
Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK). 
Via InvestorPlace
News headline image
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket ↗
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday. 
Via Benzinga
News headline image
Merck Acquires Prometheus Biosciences For $10.8B, Strengthening Its Immunology Pipeline ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning! 
Via InvestorPlace
News headline image
Nasdaq, S&P 500 Futures Muted; Analyst Says Don't Expect Good News This Earnings Season ↗
Early indications suggest that stocks could start the week on a tentative note, which was characteristic of trading during most of last week. Traders may show restraint as they look ahead to... 
Via Benzinga
News headline image
Prometheus Biosciences, XPeng And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 70.1% to $193.93... 
Via Benzinga
News headline image
RXDX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Prometheus Biosciences, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
From Merck & Co., Inc.
Via Business Wire
News headline image
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
From Prometheus Biosciences
Via GlobeNewswire
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
Prometheus Biosciences to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Prometheus Biosciences
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.